CRISPR-Cas9-mediated exon skipping as a cardioprotective strategy in Duchenne muscular dystrophy

被引：2

作者：

Wilton-Clark, Harry ^{[1
]}

Yokota, Toshifumi ^{[1
]}

机构：

[1] Univ Alberta, Dept Med Genet, Edmonton, AB, Canada

来源：

MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT | 2023年 / 30卷

关键词：

D O I：

10.1016/j.omtm.2023.08.013

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

引用

页码：500 / 501

页数：2

共 50 条

[21] Exon-skipping therapy for Duchenne muscular dystrophy [J].

Nakamura, Akinori ;

Takeda, Shin'ichi .

LANCET, 2011, 378 (9791) :546-547

[22] Exon-skipping advances for Duchenne muscular dystrophy [J].

Echevarria, Lucia ;

Aupy, Philippine ;

Goyenvalle, Aurelie .

HUMAN MOLECULAR GENETICS, 2018, 27 (R2) :R163-R172

[23] Clinical trials of exon skipping in Duchenne muscular dystrophy [J].

Mendell, Jerry R. ;

Sahenk, Zarife ;

Rodino-Klapac, Louise R. .

EXPERT OPINION ON ORPHAN DRUGS, 2017, 5 (09) :683-690

[24] Exon-skipping therapy for Duchenne muscular dystrophy [J].

Bhagavati, Satyakam .

LANCET, 2012, 379 (9811) :E10-E10

[25] The Potential of Exon Skipping for Treatment for Duchenne Muscular Dystrophy [J].

Partridge, Terence .

JOURNAL OF CHILD NEUROLOGY, 2010, 25 (09) :1165-1170

[26] Optimization of therapeutic antisense-mediated exon skipping for Duchenne muscular dystrophy [J].

Aartsma-Rus, Annemieke ;

Heemskerk, Hans ;

De Winter, Christa ;

Janson, Anneke ;

Van Ommen, Gert-Jan ;

Van Deutekom, Judith .

HUMAN GENE THERAPY, 2007, 18 (10) :983-984

[27] Development of Antisense-Mediated Exon Skipping as a Treatment for Duchenne Muscular Dystrophy [J].

Heemskerk, Hans ;

de Winter, Christa L. ;

van Ommen, Gert-Jan B. ;

van Deutekom, Judith C. T. ;

Aartsma-Rus, Annemieke .

OLIGONUCLEOTIDE THERAPEUTICS, 2009, 1175 :71-79

[28] CRISPR-Cas9mediated endogenous utrophin upregulation improves Duchenne Muscular Dystrophy [J].

Guiraud, S. ;

Ralu, M. ;

Galbiati, P. ;

Dastida, S. ;

Mazed, F. ;

Amor, F. ;

de Cian, A. ;

Richard, I. ;

Ronzitti, G. ;

Tedesco, F. S. ;

Amendola, M. .

HUMAN GENE THERAPY, 2025, 36 (3-4) :E161-E162

[29] Applications of CRISPR/Cas9 for the Treatment of Duchenne Muscular Dystrophy [J].

Lim, Kenji Rowel Q. ;

Yoon, Chantal ;

Yokota, Toshifumi .

JOURNAL OF PERSONALIZED MEDICINE, 2018, 8 (04)

[30] CRISPR-Cas9 mediated endogenous utrophin upregulation improves Duchenne muscular dystrophy [J].

Guiraud, S. ;

Dastidar, S. ;